Načítá se...
(18)F-Fluoride PET/CT tumor burden quantification predicts survival in breast cancer
PURPOSE: In bone-metastatic breast cancer patients, there are no current imaging biomarkers to identify which patients have worst prognosis. The purpose of our study was to investigate if skeletal tumor burden determined by (18)F-Fluoride PET/CT correlates with clinical outcomes and may help define...
Uloženo v:
| Vydáno v: | Oncotarget |
|---|---|
| Hlavní autoři: | , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Impact Journals LLC
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5482633/ https://ncbi.nlm.nih.gov/pubmed/28415595 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.16418 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|